GE HealthCare’s CARESCAPE Canvas Patient Monitoring Platform Receives FDA Clearance

Rhea-AI Summary

GE HealthCare (Nasdaq: GEHC) has received US FDA 510(k) clearance for its CARESCAPE Canvas patient monitoring platform. This innovation enhances patient care with a unified, flexible, and scalable monitoring solution, designed to adapt to the individual needs of patients. The platform features smart parameter technology that supports various patient acuity levels, with a focus on ease of use and standardization. CARESCAPE Canvas has demonstrated significant sustainability improvements, including a 53% reduction in packaging volume and a 25% reduction in energy consumption compared to earlier models. The product was awarded the prestigious iF Design Award 2023 for its excellence in medical product design. It has been approved for usage in the EU since June 2022 and is now cleared for the US market.

Positive

• US FDA clearance for CARESCAPE Canvas enhances market competitiveness.
• Product improves adaptability and efficiency in patient monitoring.
• Sustainability achievements include 53% reduced packaging volume and 25% lower energy consumption.
• Awarded the iF Design Award 2023 for innovative medical product design.

Negative

• None.

• CARESCAPE Canvas builds on GE HealthCare’s 50+ years of clinical excellence and provides a unified patient monitoring solution that is reliable, flexible, scalable and intuitive to use

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced US FDA 510(k) clearance of its CARESCAPE Canvas patient monitoring platform for precise, flexible patient care. CARESCAPE Canvas and CARESCAPE ONE are part of an adaptable ecosystem that can easily scale up and scale down monitoring capabilities based on the acuity of each individual patient, delivered on a standardized platform that drives enterprise efficiency and ease of service.

CARESCAPE Canvas in the NICU (Photo: Business Wire)

“As patient acuity and disease trends change rapidly, adaptability in the hospital setting is becoming more important. We look for ways to improve the care experience by delivering quality clinical measurements where and when they are needed, giving care providers the information they need to make the best possible clinical decisions,” Dr. Roland Schrewe, head of PICU, University of Frankfurt. “GE HealthCare’s CARESCAPE Canvas provides a precise, standardized and flexible patient monitoring solution that adapts to patient needs with the ease of switching out a cable.”

CARESCAPE Canvas is a FlexAcutity solution equipped with smart parameter technology that can be used for patients at all levels of acuity. This monitoring platform offers flexibility, standardization and ease of use by leveraging micromodules that connect with standardized medical USB technology -- simply adding or disconnecting cables equipped for various configurations enables more efficient care based on patient care needs. It is also equipped with flexible, easy to configure software and interchangeable frames for advanced parameters, enable monitoring devices to be quickly redeployed across the hospital enterprise as needed.

“This new monitoring ecosystem has the potential for a hospital to have one single unified approach to patient monitoring that can be easily tailored for each patient,” said Neal Sandy, general manager, monitoring solutions, GE HealthCare. “GE HealthCare is committed to offering flexible solutions that enable care teams to focus on the patient, not the technology. CARESCAPE Canvas’ innovative approach, where software and patient parameters can change in a very nimble manner, enable a standardized ecosystem that can adapt to changing healthcare needs.”

The CARESCAPE Canvas bedside monitor was developed and tested with the rest of GE HealthCare’s ecosystem, not only with the current devices available, but also with prior versions that are used across the 100 million patients monitored by GE HealthCare devices each year. This backward compatibility allows healthcare systems to upgrade to the latest capabilities at their pace. CARESCAPE Canvas was also developed with sustainability in mind, with a 53% reduction in packaging volume¹, 48% reduction in packaging weight compared to previous generation monitor¹, and a 25% reduction in energy consumption compared to previous models². In addition, CARESCAPE Canvas monitors made at GE HealthCare’s Helsinki site are manufactured by using 100% renewable wind electricity³.

CARESCAPE Canvas was recently awarded the world-renowned, iF Design Award 2023. The jury prize honors design achievements in all disciplines and recognized CARESCAPE Canvas for product design in medicine/health.

CARESCAPE Canvas has been approved for use in the EU since June, 2022 and is now cleared for use in the US.

ABOUT GE HEALTHCARE TECHNOLOGIES INC.

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from prevention and screening, to diagnosis, treatment, therapy, and monitoring. We are an $18 billion business with 50,000 employees working to create a world where healthcare has no limits.

Follow us on Facebook, LinkedIn, Twitter, Instagram and Insights for the latest news, or visit our website www.gehealthcare.com for more information.

-----------------------------

¹ CARESCAPE Canvas package is 53% smaller and packaging material mass is 48% lighter than the packaging of the equivalent CARESCAPE B850 monitor.
² CARESCAPE Canvas 1000 system uses 255 less energy than the CARESCAPE B850 system with the same setup.
³ CARESCAPE Canvas 1000 is produced in Finland with renewable wind energy.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230420005615/en/

GE HealthCare Media Contact:

Jennifer Purdue

M +1 267 593 9735

jennifer.purdue@ge.com

Source: GE HealthCare

FAQ

What is the CARESCAPE Canvas by GE HealthCare?

CARESCAPE Canvas is a patient monitoring platform that provides flexible and scalable solutions tailored to individual patient needs, recently cleared by the US FDA.

When did GE HealthCare receive FDA clearance for CARESCAPE Canvas?

GE HealthCare announced the FDA clearance for CARESCAPE Canvas on April 20, 2023.

What sustainability features does CARESCAPE Canvas offer?

CARESCAPE Canvas features a 53% reduction in packaging volume and a 25% decrease in energy consumption compared to previous models.

What award did CARESCAPE Canvas win?

CARESCAPE Canvas won the iF Design Award 2023 for excellence in product design in medicine and health.